4 posts in this category
We’re working hard to keep things updated but give us some grace to work with providers who are potentially changing their offerings around tirzepatide.
We’ve all been hearing about the shortage of tirzepatide or semaglutide, but what is a shortage? How does it impact compounding?
The FDA has ended the shortage for tirzepatide, essential copy compounding ends on Feb 18 and March 19
OFA vs FDA Case Join report Nov 21